46.95
前日終値:
$48.37
開ける:
$48.58
24時間の取引高:
19.18M
Relative Volume:
0.92
時価総額:
$68.04B
収益:
$20.62B
当期純損益:
$3.56B
株価収益率:
19.69
EPS:
2.3847
ネットキャッシュフロー:
$3.48B
1週間 パフォーマンス:
+0.60%
1か月 パフォーマンス:
-3.06%
6か月 パフォーマンス:
-36.43%
1年 パフォーマンス:
-56.34%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, MDT, SYK, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
46.95 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
108.79 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
93.10 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.99 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
EW
Edwards Lifesciences Corp
|
89.78 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-30 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific stock holds steady as institutional buyers build positions - Ad-hoc-news.de
Boston Scientific (NYSE:BSX) Gains Focus After Healthcare Shift - Kalkine Media
BSX|Boston Scientific Corp|Price:49.740|Chg%:+0.370 - TradingKey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Edmond DE Rothschild Holding S.A. Acquires Shares of 875,810 Boston Scientific Corporation $BSX - MarketBeat
A Look at Boston Scientific Corp (BSX) After 3.0% Gain -- GF Val - GuruFocus
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific stock trades around $50 as Q2 2026 margins and earnings expand - AD HOC NEWS
Great Lakes Advisors LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific stock holds in the low $51 range as Q2 2026 margins and EPS beat guidance - AD HOC NEWS
Boston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks - AboutLawsuits.com
Mitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp (BSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises - Yahoo Finance
Boston Scientific stock extends 7-day rebound as Q2 2026 margins expand - AD HOC NEWS
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Trivium Point Advisory LLC Invests $1.48 Million in Boston Scientific Corporation $BSX - MarketBeat
S&CO Inc. Buys Shares of 169,791 Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX - MarketBeat
Congress Large Cap Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX), What Is Behind The Latest Investor Attention? - finance.yahoo.com
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance? - Yahoo Finance
Fidelity Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall? - Yahoo Finance
Brazil CADE reviews Boston Scientific’s acquisition of Penumbra - MLex
Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses - Yahoo Finance
Union Bancaire Privee UBP SA Sells 173,105 Shares of Boston Scientific Corporation $BSX - MarketBeat
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
Here’s What Hurt Boston Scientific Corporation (BSX) in Q2 - Yahoo Finance
Boston Scientific Corporation $BSX Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Security National Bank Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
QRG Capital Management Inc. Buys 198,951 Shares of Boston Scientific Corporation $BSX - MarketBeat
NewEdge Advisors LLC Sells 27,583 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Fisher Funds Management LTD - MarketBeat
Brookstone Capital Management Sells 233,448 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific's CEO Bought $9M of His Own Stock - Quiver Quantitative
Boston Scientific (BSX) SVP Emily Woodworth adds 2,930 shares in 401(k) rebalance - Stock Titan
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals - ChartMill
Northside Capital Management LLC Purchases 49,189 Shares of Boston Scientific Corporation $BSX - MarketBeat
MiRus founder builds medtech firm worth billions after quest to save others from fate of his mentorAtlanta Business Chronicle - The Business Journals
Boston Scientific Corporation $BSX Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Boston Scientific (BSX) CFO adds 9,908 shares through discretionary 401(k) rebalancing - Stock Titan
Handelsbanken Fonder AB Sells 1,002,628 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Brokerages - marketbeat.com
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone (NYSE:BSX) - Seeking Alpha
Fidelity Series Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company - Yahoo Finance
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026? - The Motley Fool
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
Boston Scientific Corp (BSX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Habiger David C | Director |
Aug 05 '26 |
Buy |
47.59 |
2,100 |
99,937 |
17,160 |
| Habiger David C | Director |
Aug 03 '26 |
Buy |
48.07 |
1,042 |
50,084 |
14,920 |
| Habiger David C | Director |
Aug 04 '26 |
Buy |
48.59 |
140 |
6,802 |
15,060 |
| Mahoney Michael F | Chairman, President & CEO |
Aug 03 '26 |
Buy |
48.33 |
186,240 |
9,001,408 |
1,590,024 |
| LUDWIG EDWARD J | Director |
Jul 31 '26 |
Buy |
45.48 |
5,000 |
227,400 |
30,359 |
| Monson Jonathan | EVP and CFO |
Jul 01 '26 |
Option Exercise |
0.00 |
2,087 |
0 |
40,073 |
| Pegus Cheryl | Director |
May 20 '26 |
Buy |
56.49 |
1,770 |
99,987 |
1,770 |
| LUDWIG EDWARD J | Director |
May 20 '26 |
Buy |
56.68 |
3,580 |
202,914 |
25,359 |
| Habiger David C | Director |
May 20 '26 |
Buy |
55.92 |
2,250 |
125,819 |
13,878 |
| Habiger David C | Director |
May 19 '26 |
Buy |
56.95 |
2,200 |
125,279 |
11,628 |
大文字化:
|
ボリューム (24 時間):